Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.2210/pdb6rua/pdb
Abstract: Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for pr... read more here.
Keywords: development potent; selective inhibitors; potent reversible; inhibitors butyrylcholinesterase ... See more keywords